SurModics Inc Market Cap ($614.51 Million)
Market Cap & Net Worth: SurModics Inc (SRDX)
SurModics Inc market cap. SurModics Inc (NASDAQ:SRDX) has a market capitalization of $614.51 Million ($614.51 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10846 globally and #2873 in its home market, demonstrating a 57.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SurModics Inc's stock price $42.98 by its total outstanding shares 14297623 (14.30 Million). Also see how efficiently does SurModics Inc generate cash for how efficiently the company converts equity into cash flow.
SurModics Inc Market Cap History (2015–2025)
SurModics Inc market cap history from 2015 to 2025. Data shows growth from $289.81 Million to $614.51 Million (6.98% CAGR). Check SurModics Inc stock quote for real-time trading data and today's change.
Index Memberships
SurModics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.02% | #301 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1122 of 3165 |
Weight: SurModics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
SurModics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SurModics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of SurModics Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.49x
SurModics Inc's market cap is 4.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $289.81 Million | $61.90 Million | $13.45 Million | 4.68x | 21.55x |
| 2016 | $363.16 Million | $71.37 Million | $9.98 Million | 5.09x | 36.37x |
| 2017 | $400.33 Million | $73.11 Million | $3.93 Million | 5.48x | 101.97x |
| 2018 | $675.71 Million | $81.34 Million | -$4.46 Million | 8.31x | N/A |
| 2019 | $592.35 Million | $100.08 Million | $7.59 Million | 5.92x | 78.02x |
| 2020 | $622.23 Million | $94.86 Million | $1.12 Million | 6.56x | 554.08x |
| 2021 | $688.43 Million | $105.14 Million | $4.24 Million | 6.55x | 162.48x |
| 2022 | $487.83 Million | $99.95 Million | -$27.27 Million | 4.88x | N/A |
| 2023 | $519.72 Million | $132.58 Million | -$1.54 Million | 3.92x | N/A |
| 2024 | $566.19 Million | $126.08 Million | -$11.54 Million | 4.49x | N/A |
Competitor Companies of SRDX by Market Capitalization
Companies near SurModics Inc in the global market cap rankings as of November 5, 2026. Also see balance sheet size of SurModics Inc for a full breakdown of the balance sheet.
Key companies related to SurModics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of SurModics Inc (2015–2025)
Market capitalization of SurModics Inc from 2015 to today. Between 2015 and today, SurModics Inc's market cap moved from $289.81 Million to $ 614.51 Million, with a yearly change of 6.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $614.51 Million | +8.54% |
| 2024 | $566.19 Million | +8.94% |
| 2023 | $519.72 Million | +6.54% |
| 2022 | $487.83 Million | -29.14% |
| 2021 | $688.43 Million | +10.64% |
| 2020 | $622.23 Million | +5.04% |
| 2019 | $592.35 Million | -12.34% |
| 2018 | $675.71 Million | +68.79% |
| 2017 | $400.33 Million | +10.24% |
| 2016 | $363.16 Million | +25.31% |
| 2015 | $289.81 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of SurModics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $614.51 Million USD |
| MoneyControl | $614.51 Million USD |
| MarketWatch | $614.51 Million USD |
| marketcap.company | $614.51 Million USD |
| Reuters | $614.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SurModics Inc
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more